Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 15/2006

01-10-2006 | Adis Drug Profiles

Vildagliptin

A Viewpoint by Michelle V. Gordon and Anna C. Calkin

Authors: Michelle V. Gordon, Anna C. Calkin

Published in: Drugs | Issue 15/2006

Login to get access

Excerpt

Although it is almost 10 years since the UK Prospective Diabetes Study established that improved glycaemic control is associated with reduced microvascular complications and a trend toward reduced macrovascular complications in type 2 diabetes mellitus,[1] treatment regimens that provide optimal glycaemic control have yet to be determined. The recent development of dipeptidyl peptidase-4 (DPP-4) inhibitors, such as vildagliptin, offers promise in improving glycaemic control in type 2 diabetes. …
Literature
1.
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000 Aug 12; 321(7258): 405–12PubMedCrossRef
Metadata
Title
Vildagliptin
A Viewpoint by Michelle V. Gordon and Anna C. Calkin
Authors
Michelle V. Gordon
Anna C. Calkin
Publication date
01-10-2006
Publisher
Springer International Publishing
Published in
Drugs / Issue 15/2006
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200666150-00009

Other articles of this Issue 15/2006

Drugs 15/2006 Go to the issue

Review Article

Familial Dyslipidaemias

Adis Drug Profiles

Vildagliptin

Leading Article

Novel Therapies for the Treatment of Small-Cell Lung Cancer

Adis Drug Profile

Tramadol Extended-Release Tablets

Adis Drug Profiles

Tramadol Extended-Release Tablets

Leading Article

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus